1 戚玮琳, 范维琥, 戚文航.萘哌地尔的药理学研究和临床应用[J].中国新药杂志, 2001;10:579-82
2 Takei R, Ikegaki I, Shibata K.Naftopidil, a novel alpha1-adrenoceptor antagnist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors[J].J Pharmacol , 1999;79:447-54
3 居小兵, 吴宏飞, 苏建堂.萘哌地尔治疗良性前列腺增生的疗效观察[J].中华男科学, 2002;8:286-8
4 李宁忱, 张晓春, 王晓峰, 吴宏飞, 那彦裙, 郭应禄.新型α1-肾上腺素能受体阻滞剂萘哌地尔治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志, 2004;25:637-40
5 徐叔云, 卞如濂, 陈修, 主编.药理学实验方法[M].第3版.北京:人民卫生出版社, 2000:1553-4
6 Kyprianou N, Tu H, Jacobs SC.Apoptotic versus proliferative activities in human benign prostatic hyperplasia[J].Hum Pathol,1996;27:668-75
7 Kyprianou N.Doxazosin and terazosin suppress Prostate growth by inducing apoptosis:clinical significance[J].J Urol, 2003;169:1520-5
8 眭玉霞, 孙安盛, 吴芹, 余丽梅, 黄燮南, 石京山, 等.萘哌地尔衍生物BWYJ 对大鼠血压及猫血流动力学的影响 Chin J Clin Pharmacol Ther 2006 Aug;11(8)[J].中国临床药理学与治疗学, 2005;10:852-5
9 王会玖, 黄燮南, 蒋青松, 吴芹, 孙安盛, 石京山.萘哌地尔衍生物BWYJ 扩血管效应及其机理研究[J].中国临床药理学与治疗学杂志, 2004;9:1393-7
10 Matityahou A, Rosenzweig N, Golomb E.Rapid proliferation of prostatic epithelial cells in spontaneously hypertensive rats:A model of spontaneous hypertension and prostate hyperplasia[J].J Androl, 2003;24:263-9
11 Marinese D, Patel R, Walden PD.Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice[J].Prostate, 2003;54:230-7
12 Hammarsten J, Hogstedt B.Hyperinsulinaemia as a risk factor for developing benign prostatic hyperPlasia[J].Euro Urol,2001;39:151-8 |
